Synercid (quinupristin-dalfopristin) is now available for emergency use

February 1996

Rhone-Poulenc Rorer's investigational antibiotic Synercid (quinupristin-dalfopristin) is now available for emergency use......

Exclusive Subscriber Content

Best in class medication learning
Concise recommendations
Hundreds of practical resources

Subscribe Now Learn More

Login to access this content.

Login

Table of Contents

HUGE lawsuit by pharmacists against the drug manufacturers
beta carotene supplements DON'T prevent cancer or heart disease
One of the hottest HERBAL supplements these days is ginkgo
questions about DHEA for aging
Anticonvulsants Tegretol (carbamazepine) SUSPENSION
Anticonvulsants lots of confusion about when to test drug levels in patients taking anticonvulsants
methylphenidate (Ritalin) might be carcinogenic
Rilutek (riluzole) tablets in the U.S.
Cardiology cholesterol-lowering drugs might increase the risk of cancer
Cardiology The question about whether calcium channel blockers are safe is flaring up again
Naltrexone (ReVia) is now approved for treating alcoholism
Infectious Diseases new antibiotic called Cedax (ceftibuten)
Infectious Diseases Famvir (famciclovir) for genital herpes
Infectious Diseases Synercid (quinupristin-dalfopristin) is now available for emergency use
Dermatology Renova, a new form of Retin-A (tretinoin) for wrinkles
Hematology Oncology Kytril (granisetron), to prevent nausea and vomiting from cancer chemotherapy
Hematology Oncology using Taxol (paclitaxel) as INITIAL therapy for advanced ovarian cancer
Hematology Oncology two new therapies for advanced breast cancer
Hematology Oncology Arimidex (ah-RIM-i-dex) is a brand-new drug
Sexually Transmitted Diseases Canadian guidelines for treating gonorrhea and chlamydia have just been revised